Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fralick

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Annals of Internal Medicine|January 1, 2019
Fracture Risk After Initiation of Use of Canagliflozin: A Cohort StudyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
The Oncologist|September 28, 2013
Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlinesMichael Fralick, Monali Ray, Christina Fung, et al.
Plos Medicine|October 22, 2019
Desmopressin and the risk of hyponatremia: A population-based cohort studyMichael Fralick, Sebastian Schneeweiss, Christopher J D Wallis, et al.
Annals of Internal Medicine|July 2, 2019
Fracture Risk After Initiation of Use of CanagliflozinMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetesMichael Fralick, Martin Kulldorff, Donald Redelmeier, et al.
Annals of Internal Medicine|March 10, 2020
Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort StudyMichael Fralick, Michael Colacci, Sebastian Schneeweiss, et al.
Nature Reviews. Endocrinology|January 18, 2022
Global accessibility of therapeutics for diabetes mellitusMichael Fralick, Alicia J Jenkins, Kamlesh Khunti, et al.
European Journal of Haematology|March 10, 2022
Systematic review of hematuria and acute renal failure with tranexamic acidStephanie G Lee, John Fralick, Christopher J D Wallis, et al.
BMJ (Clinical Research Ed.)|August 27, 2020
Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort studyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
JAMA Internal Medicine|September 8, 2020
Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic DissectionChandrasekar Gopalakrishnan, Katsiaryna Bykov, Michael A Fischer, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|January 1, 2019
Fracture Risk After Initiation of Use of Canagliflozin: A Cohort StudyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
The Oncologist|September 28, 2013
Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlinesMichael Fralick, Monali Ray, Christina Fung, et al.
Plos Medicine|October 22, 2019
Desmopressin and the risk of hyponatremia: A population-based cohort studyMichael Fralick, Sebastian Schneeweiss, Christopher J D Wallis, et al.
Annals of Internal Medicine|July 2, 2019
Fracture Risk After Initiation of Use of CanagliflozinMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetesMichael Fralick, Martin Kulldorff, Donald Redelmeier, et al.
Annals of Internal Medicine|March 10, 2020
Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort StudyMichael Fralick, Michael Colacci, Sebastian Schneeweiss, et al.
Nature Reviews. Endocrinology|January 18, 2022
Global accessibility of therapeutics for diabetes mellitusMichael Fralick, Alicia J Jenkins, Kamlesh Khunti, et al.
European Journal of Haematology|March 10, 2022
Systematic review of hematuria and acute renal failure with tranexamic acidStephanie G Lee, John Fralick, Christopher J D Wallis, et al.
BMJ (Clinical Research Ed.)|August 27, 2020
Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort studyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.
JAMA Internal Medicine|September 8, 2020
Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic DissectionChandrasekar Gopalakrishnan, Katsiaryna Bykov, Michael A Fischer, et al.
Pageof 20